Visual Recovery of Dysthyroid Optic Neuropathy With Teprotumumab

J Neuroophthalmol. 2022 Jun 1;42(2):e491-e493. doi: 10.1097/WNO.0000000000001298. Epub 2021 Jun 25.
No abstract available

MeSH terms

  • Antibodies, Monoclonal, Humanized / therapeutic use
  • Humans
  • Optic Nerve
  • Optic Nerve Diseases* / diagnosis
  • Optic Nerve Diseases* / drug therapy
  • Optic Nerve Diseases* / etiology

Substances

  • Antibodies, Monoclonal, Humanized
  • teprotumumab